Poland· PL-100217280
Ebetrexat
A methotrexate product containing methotrexatum, registered in Poland by Ebewe Pharma Ges.m.b.H Nfg. KG. The same ATC class is registered in 15 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Methotrexate is registered in 15 of 19 countries.
Countries holding a registration under ATC L04AX03 (methotrexate), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 9 of them publish a price we can compare per daily dose
Methotrexate · ATC L04AX03
15 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of methotrexate costs, country by country.
Normalised to the WHO defined daily dose (2.5 mg), the median price runs from $0.16 in United States to $5.98 in Switzerland — a ×38 gap.
- 3 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
- US figures are pharmacy acquisition cost (CMS NADAC), not retail
Methotrexate · price per daily dose (2.5 mg)
USD · FX 28 Sept 2026
- CH Switzerland$5.98
- IT Italy$0.20
- US United States$0.16 (acquisition cost)
The record
At a glance
URPL (Poland)- Active substance
- Methotrexatum
- Manufacturer
- Ebewe Pharma Ges.m.b.H Nfg. KG
- Country
- Poland (PL)
- ATC code
- L04AX03
- ATC class
- Methotrexate
- Defined daily dose
- 2.5 mg, O
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 50
7 priced- gtin05907626702101
- gtin05907626702118
- gtin059099907352424 amp.-strz.po 1 mlPLN 222.54
- gtin059099907352734 amp.-strz.po 1,25 mlPLN 274.9
- gtin059099907353034 amp.-strz.po 1,5 mlPLN 327.29
- gtin05907626702149
- gtin059076267018521 amp.-strz.a 0,375 mlPLN 23.31
- gtin05907626702262
- gtin059076267018694 amp.-strz.po 0,375 mlPLN 89.09
- gtin059076267019204 amp.-strz.po 0,5 mlPLN 116.29
- gtin059076267020404 amp.-strz.po 0,75 mlPLN 169.71
- gtin05907626701944
- gtin05907626701951
- gtin05907626701968
- gtin05907626701975
- gtin05907626701982
- gtin05907626701999
- gtin05907626702002
- gtin05909990735235
- gtin05909990735259
- gtin05909990735266
- gtin05909990735280
- gtin05909990735297
- gtin05909990735327
- gtin05909990796878
- gtin05909990796885
- gtin05909990796892
- gtin05909990796908
- gtin05909990796922
- gtin05907626701876
- gtin05907626701883
- gtin05907626701890
- gtin05907626701906
- gtin05907626701913
- gtin05907626701937
- gtin05907626702019
- gtin05907626702026
- gtin05907626702033
- gtin05907626702057
- gtin05907626702064
- gtin05907626702071
- gtin05907626702088
- gtin05907626702095
- gtin05907626702125
- gtin05907626702132
- gtin05907626702156
- gtin05907626702163
- gtin05907626702194
- gtin05907626702200
- gtin05907626702217
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
929 interactions on record for methotrexate.
Graded by severity as the source publishes them — 107 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Methotrexate · interactions on record
929 records
- 107 severe
- 466 moderate
- 17 minor
- 309 info
Most severe, free to view
- OmeprazoleA02BC01severe
- PantoprazoleA02BC02severe
- LansoprazoleA02BC03severe
- RabeprazoleA02BC04severe
30 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Methotrexate in 17 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- BelgiumEbetrexat 20 mg/mlSandoz
- SwitzerlandMethrexx 10 mg/0.5 ml, Injektionslösung in einer FertigspritzeSandoz Pharmaceuticals AG
- SpainBERTANEL 20 mg/1 ml SOLUCION INYECTABLE EN JERINGA PRECARGADAEbewe Pharma Ges.M.B.H. Nfg.Kg
- SwedenEbetrex 20 mg/ml Injektionsvätska, lösning i förfylld sprutaEBEWE Pharma Ges.m.b.H.Nfg.KG
- CzechiaFOXIEMOeasyMed s.r.o., Praha 10
- United KingdomEbetrex 10mg/1ml solution for injection pre-filled syringesSandoz Ltd
- NetherlandsBasitrin 10 mg=0,267 ml, oplossing voor injectie in een voorgevulde spuit 37,5 mg/mlBasic Pharma Manufacturing B.V.
- FinlandEbetrexEbewe Pharma Ges.m.b.H. Nfg.KG
Authorised across Europe · EMA
The same active substance is authorised in 30 EEA countries. Names it is sold under:
- Austria · Ebetrexat, Methofill
- Belgium · Basitrin, Emthexate
- Bulgaria · Ebetrexat, Инжексат
- Cyprus · Injexate, Methotrexate Accord
- Czechia · Foxiemo, Injexate
- Germany · Lantarel, Lantarel Fs
- Denmark · Ebetrex, Emthexate
- Estonia · Ebetrex, Metex
- Spain · Bertanel, Imeth
- Finland · Ebetrex, Injexate
- France · Imenor, Imeth
- United Kingdom (Northern Ireland) · Ebetrex, Injexate
- Greece · Methobion, Methotrexate Pfizer
- Croatia · Ebetrexat, Methofill
- Hungary · Ebetrexat, Methofill
- Ireland · Methofill, Methotrexate Abcur
- Iceland · Jylamvo, Methotrexat Ebewe
- Italy · Afslamet, Immutrex
- Liechtenstein · Jylamvo, Nordimet
- Lithuania · Ebetrexat, Metex
- Luxembourg · Emthexate, Emthexate Teva Pharma
- Latvia · Ebetrex, Metex
- Malta · Methotrexate Aspire Pharma (Malta)
- Netherlands · Basitrin, Ebetrex
- Norway · Ebetrex, Jylamvo
- Portugal · Fauldexato, Ledertrexato
- Romania · Methotrexat Ebewe, Metorthrit
- Sweden · Ebetrex, Injexate
- Slovenia · Methofill, Metoject
- Slovakia · Foxiemo, Injexate
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/e543e1bc-e13a-474f-a57a-b38e55837b04 GET /v1/drugs/e543e1bc-e13a-474f-a57a-b38e55837b04?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Roztwór do wstrzykiwań w ampułko-strzykawce",
"source": "urpl",
"strength": "20 mg/ml",
"packaging": "05909990735235 ¦ Rp ¦ 53626\n1 amp.-strzyk. 1 ml\n05909990735242 ¦ Rp ¦ 53629\n4 amp.-strzyk. 1 ml\n05909990735259 ¦ Rp ¦ 53630\n5 amp.-strzyk. 1 ml\n05909990735266 ¦ Rp ¦ 53631\n1 amp.-strzyk. 1,25 ml\n05909990735273 ¦ Rp ¦ 53632\n4 amp.-strzyk. 1,25 ml\n05909990735280 ¦ Rp ¦ 53633\n5 amp.-strzyk. 1,25 ml\n05909990735297 ¦ Rp ¦ 53634\n1 amp.-strzyk. 1,5 ml\n05909990735303 ¦ Rp ¦ 53635\n4 amp.-strzyk. 1,5 ml\n05909990735327 ¦ Rp ¦ 53636\n5 amp.-strzyk. 1,5 ml\n05909990796878 ¦ Rp ¦ 59809\n6 amp.-strzyk. 1 ml\n05909990796885 ¦ Rp ¦ 59810\n12 amp.-strzyk. 1 ml\n05909990796892 ¦ Rp ¦ 59812\n6 amp.-strzyk. 1,25 ml\n05909990796908 ¦ Rp ¦ 59813\n12 amp.-strzyk. 1,25 ml\n05909990796922 ¦ Rp ¦ 59814\n6 amp.-strzyk. 1,5 ml\n05909990796939 ¦ Rp ¦ 59815\n12 amp.-strzyk. 1,5 ml\n05907626701821 ¦ Rp ¦ 82919\n30 amp.-strzyk. 1 ml\n05907626701838 ¦ Rp ¦ 82920\n30 amp.-strzyk. 1,25 ml\n05907626701845 ¦ Rp ¦ 82921\n30 amp.-strzyk. 1,5 ml\n05907626701852 ¦ Rp ¦ 82922\n1 amp.-strzyk. 0,375 ml\n05907626701869 ¦ Rp ¦ 82923\n4 amp.-strzyk. 0,375 ml\n05907626701876 ¦ Rp ¦ 82924\n5 amp.-strzyk. 0,375 ml\n05907626701883 ¦ Rp ¦ 82925\n6 amp.-strzyk. 0,375 ml\n05907626701890 ¦ Rp ¦ 82926\n12 amp.-strzyk. 0,375 ml\n05907626701906 ¦ Rp ¦ 82927\n30 amp.-strzyk. 0,375 ml\n05907626701913 ¦ Rp ¦ 82928\n1 amp.-strzyk. 0,5 ml\n05907626701920 ¦ Rp ¦ 82929\n4 amp.-strzyk. 0,5 ml\n05907626701937 ¦ Rp ¦ 82930\n5 amp.-strzyk. 0,5 ml\n05907626701944 ¦ Rp ¦ 82931\n6 amp.-strzyk. 0,5 ml\n05907626701951 ¦ Rp ¦ 82932\n12 amp.-strzyk. 0,5 ml\n05907626701968 ¦ Rp ¦ 82933\n30 amp.-strzyk. 0,5 ml\n05907626701975 ¦ Rp ¦ 82934\n1 amp.-strzyk. 0,625 ml\n05907626701982 ¦ Rp ¦ 82935\n4 amp.-strzyk. 0,625 ml\n05907626701999 ¦ Rp ¦ 82936\n5 amp.-strzyk. 0,625 ml\n05907626702002 ¦ Rp ¦ 82937\n6 amp.-strzyk. 0,625 ml\n05907626702019 ¦ Rp ¦ 82938\n12 amp.-strzyk. 0,625 ml\n05907626702026 ¦ Rp ¦ 82939\n30 amp.-strzyk. 0,625 ml\n05907626702033 ¦ Rp ¦ 82940\n1 amp.-strzyk. 0,75 ml\n05907626702040 ¦ Rp ¦ 82941\n4 amp.-strzyk. 0,75 ml\n05907626702057 ¦ Rp ¦ 82942\n5 amp.-strzyk. 0,75 ml\n05907626702064 ¦ Rp ¦ 82943\n6 amp.-strzyk. 0,75 ml\n05907626702071 ¦ Rp ¦ 82944\n12 amp.-strzyk. 0,75 ml\n05907626702088 ¦ Rp ¦ 82945\n30 amp.-strzyk. 0,75 ml\n05907626702095 ¦ Rp ¦ 82946\n1 amp.-strzyk. 0,875 ml\n05907626702101 ¦ Rp ¦ 82947\n4 amp.-strzyk. 0,875 ml\n05907626702118 ¦ Rp ¦ 82948\n5 amp.-strzyk. 0,875 ml\n05907626702125 ¦ Rp ¦ 82949\n6 amp.-strzyk. 0,875 ml\n05907626702132 ¦ Rp ¦ 82950\n12 amp.-strzyk. 0,875 ml\n05907626702149 ¦ Rp ¦ 82951\n30 amp.-strzyk. 0,875 ml\n05907626702156 ¦ Rp ¦ 82952\n1 amp.-strzyk. 1,125 ml\n05907626702163 ¦ Rp ¦ 82953\n4 amp.-strzyk. 1,125 ml\n05907626702170 ¦ Rp ¦ 82954\n5 amp.-strzyk. 1,125 ml\n05907626702187 ¦ Rp ¦ 82955\n6 amp.-strzyk. 1,125 ml\n05907626702194 ¦ Rp ¦ 82956\n12 amp.-strzyk. 1,125 ml\n05907626702200 ¦ Rp ¦ 82957\n30 amp.-strzyk. 1,125 ml\n05907626702217 ¦ Rp ¦ 82958\n1 amp.-strzyk. 1,375 ml\n05907626702224 ¦ Rp ¦ 82959\n4 amp.-strzyk. 1,375 ml\n05907626702231 ¦ Rp ¦ 82960\n5 amp.-strzyk. 1,375 ml\n05907626702248 ¦ Rp ¦ 82961\n6 amp.-strzyk. 1,375 ml\n05907626702255 ¦ Rp ¦ 82962\n12 amp.-strzyk. 1,375 ml\n05907626702262 ¦ Rp ¦ 82963\n30 amp.-strzyk. 1,375 ml",
"substance": "Methotrexatum natricum 21.94 mg/ml",
"common_name": "Methotrexatum",
"pl_product_id": "100217280",
"pozwolenie_nr": "16034",
"auth_procedure": "DCP",
"authorisation_validity": "Bezterminowe"
}See everything about methotrexate.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.